교육시간 |
2019-06-20 |
09:00~09:25 |
Staging and pathologic features related to cancer biology |
김규래 |
울산의대 |
교육시간 |
2019-06-20 |
09:25~09:50 |
Oncologic imaging: Evolving images for evolving treatments |
김경원 |
울산의대 |
교육시간 |
2019-06-20 |
09:50~10:15 |
Armamentarium in medical oncology: Old and new |
박인근 |
가천의대 |
교육시간 |
2019-06-20 |
10:15~10:40 |
Clinical trials: How to add translational components |
최윤지 |
고려의대 |
교육시간 |
2019-06-20 |
09:00~09:25 |
Pressurized intraperitoneal aerosol chemotherapy |
안상훈 |
서울의대 |
교육시간 |
2019-06-20 |
09:25~09:50 |
Value of extra nodal tumor deposit and extramural vascular invasion in colorectal cancer |
박선진 |
경희의대 |
교육시간 |
2019-06-20 |
09:50~10:15 |
Alternative preoperative treatment in advanced rectal cancer |
김혜진 |
경북의대 |
교육시간 |
2019-06-20 |
10:15~10:40 |
Update of treatment for peritoneal metastasis in gastric cancer |
김종한 |
고려의대 |
교육시간 |
2019-06-20 |
09:00~09:30 |
Radiation therapy and anti-tumor immunity; immunological mechanisms of abscopal effect |
박세광 |
인제의대 |
교육시간 |
2019-06-20 |
09:30~10:00 |
A strategy of the combination of radiotherapy and immune checkpoint blockade |
김진호 |
서울의대 |
교육시간 |
2019-06-20 |
10:00~10:30 |
Propagation of abscopal effect from local therapy |
박경화 |
고려의대 |
토론 |
2019-06-20 |
10:30~10:40 |
Q&A Discussion |
|
|
교육시간 |
2019-06-20 |
09:00~09:25 |
Application of proteomics in translational cancer research |
김재영 |
충남대 |
교육시간 |
2019-06-20 |
09:25~09:50 |
Extracellular vesicles in cancer: Cell-to-cell mediators of metastasis |
김한상 |
연세의대 |
교육시간 |
2019-06-20 |
09:50~10:15 |
Application of robotic surgery for advanced gynecologic cancers |
백지흠 |
아주의대 |
교육시간 |
2019-06-20 |
10:15~10:40 |
The defense mechanisms of polarized epithelial cells to suppress EMT and tumor metastasis |
정해윤 |
성균관의대 |
휴식 |
2019-06-20 |
10:40~11:00 |
Coffee Break |
|
|
교육시간 |
2019-06-20 |
11:00~11:30 |
How do tumor cells grow within lymph node? |
고규영 |
카이스트 |
교육시간 |
2019-06-20 |
11:30~12:20 |
Progress through the new American NCI National Clinical Trials Network: NRG Oncology as a case study |
Walter J. Curran |
Winship Cancer Institute of Emory University, USA |
교육시간 |
2019-06-20 |
12:20~13:20 |
Individualized treatment decision for optimal sequence in mCRC, with aflibercept |
TBA |
TBA |
교육시간 |
2019-06-20 |
12:20~13:20 |
Liposomal irinotecan, new hope for the treatment of metastatic pancreatic cancer |
유창훈 |
울산의대 |
교육시간 |
2019-06-20 |
12:20~13:20 |
Cutting-edge front-line treatment for advanced non-small cell lung cancer |
김태민 |
서울의대 |
교육시간 |
2019-06-20 |
12:20~13:20 |
Therapeutic strategy for maximizing overall survival for ALK/ROS1+ NSCLC |
Takashi Seto |
Kyushu Cancer Center, Japan |
교육시간 |
2019-06-20 |
13:20~13:45 |
Epigenetic alterations in gastric epithelial and stromal cells as diagnostic and therapeutic targets |
Toshikazu Ushijima |
National Cancer Center Research Institute, Japan |
교육시간 |
2019-06-20 |
13:45~14:10 |
Integrated proteogenomic analysis of gastric cancers |
황대희 |
서울대 |
교육시간 |
2019-06-20 |
14:10~14:35 |
Stem cell origin of gastric cancers and their niche |
Yoku Hayakawa |
The University of Tokyo, Japan |
교육시간 |
2019-06-20 |
14:35~15:00 |
Targeting interaction between fibrotic stroma and cancer cell in gastric cancer |
허훈 |
아주의대 |
교육시간 |
2019-06-20 |
13:20~13:45 |
The first biomarker-defined tumor indication: Pembrolizumab for MSI-H tumors |
Kenneth Emancipator |
MSD, USA |
교육시간 |
2019-06-20 |
13:45~14:10 |
Development of larotrectinib in NTRK fusion positive tumors |
TBA |
TBA |
교육시간 |
2019-06-20 |
14:10~14:35 |
Challenges in trial design in tissue agnostic drug development |
Susan Galloway Hilsenbeck |
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, USA |
교육시간 |
2019-06-20 |
14:35~15:00 |
Challenges of tissue agnostic drug approval and utility |
안명주 |
성균관의대 |
교육시간 |
2019-06-20 |
13:20~13:45 |
Thyroid oncology I |
Xiaolei Wang |
The Cancer Institute and Hospital, Chinese Academy of Medical Sciences, China |
교육시간 |
2019-06-20 |
13:45~14:10 |
Heand and neck cancer I |
Laiping Zhong |
Shanghai Ninth People’s Hospital, Shanghai jiaotong university School of Medicine, China |
교육시간 |
2019-06-20 |
14:10~14:35 |
Thyroid oncology II |
TBA |
TBA |
교육시간 |
2019-06-20 |
14:35~15:00 |
Heand and neck cancer II |
TBA |
TBA |
교육시간 |
2019-06-20 |
13:20~13:55 |
Unleashing the innate and adoptive immune systems for the treatment of pediatric solid tumors |
Robbie G. Majzner |
Stanford University School of Medicine, USA |
교육시간 |
2019-06-20 |
13:55~14:30 |
Immune checkpoint blockade immunotherapy for advanced solid tumor of childhood |
Yasushi Fuchimoto |
International University of Health and Welfare School of Medicine , Japan |
교육시간 |
2019-06-20 |
14:30~15:00 |
Exploring combination therapy with B cell and monocyte-based cancer vaccines |
강창율 |
서울대 약대 |
교육시간 |
2019-06-20 |
13:20~13:40 |
Establishing database platform of KGOG |
최철훈 |
성균관의대 |
교육시간 |
2019-06-20 |
13:40~14:00 |
Beyond the specialty: Integration of inter-departmental ability |
문용화 |
차의대 |
교육시간 |
2019-06-20 |
14:00~14:20 |
Tips and tricks of recruiting study population |
박원 |
성균관의대 |
교육시간 |
2019-06-20 |
14:20~14:40 |
Development of ‘good’ clinical trial protocol |
강석범 |
국립암센터 |
토론 |
2019-06-20 |
14:40~15:00 |
Panel Discussion |
|
|
교육시간 |
2019-06-20 |
13:20~13:45 |
Mitochondrial UQCRB, a new player in tumor angiogenesis |
권호정 |
연세대 |
교육시간 |
2019-06-20 |
13:45~14:10 |
Endothelial Notch signaling promotes tumor progression and metastasis |
Andreas Fischer |
German Cancer Research Center (DKFZ), Germany |
교육시간 |
2019-06-20 |
14:10~14:35 |
Deciphering the origin of somatic mutations in brain tumors |
이정호 |
카이스트 |
교육시간 |
2019-06-20 |
14:35~15:00 |
Vascular abnormalities in mouse brain tumor models |
김인준 |
카이스트 |
교육시간 |
2019-06-20 |
13:20~13:50 |
Recent updates in combination of pembrolizumab and TKIs |
TBA |
TBA |
교육시간 |
2019-06-20 |
13:50~14:20 |
Pembrolizumab for MSI-H solid tumor |
TBA |
TBA |
교육시간 |
2019-06-20 |
14:20~14:50 |
Durable response after discontinuation of pembrolizumab and re-challenge for patients experiencing progression after response |
TBA |
TBA |
토론 |
2019-06-20 |
14:50~15:00 |
Q&A Discussion |
|
|
휴식 |
2019-06-20 |
15:00~15:20 |
Coffee Break |
|
|
교육시간 |
2019-06-20 |
15:20~15:45 |
Recent challenges for precision medicine in colorectal cancer |
Hideo Baba |
Graduate School of Medical Sciences, Kumamoto University, Japan |
교육시간 |
2019-06-20 |
15:45~16:10 |
Next-generation sequencing-based clinical sequencing: Toward precision medicine in colorectal cancer |
Toshifumi Wakai |
Niigata University Graduate School of Medical and Dental Sciences, Japan |
교육시간 |
2019-06-20 |
16:10~16:35 |
Application of clinical NGS in colorectal cancer: Asan Medical Center experience |
김지훈 |
울산의대 |
교육시간 |
2019-06-20 |
16:35~17:00 |
Precision medicine in colorectal cancer: Case review |
김진원 |
서울의대 |
교육시간 |
2019-06-20 |
15:20~15:55 |
Pragmatic clinical research and barriers |
Edward Kim |
Atrium Health Levine Cancer Institute, USA |
교육시간 |
2019-06-20 |
15:55~16:25 |
Untold reality in medical device development |
오승준 |
서울의대 |
교육시간 |
2019-06-20 |
16:25~17:00 |
Innovations in clinical trials and future |
김지현 |
서울의대 |
교육시간 |
2019-06-20 |
15:20~15:40 |
Current status and future of genetic test |
임명철 |
국립암센터 |
교육시간 |
2019-06-20 |
15:40~16:00 |
Mismatch repair gene and gynecologic cancer |
최민철 |
차의대 |
교육시간 |
2019-06-20 |
16:00~16:20 |
BRCAness and synthetic lethality |
이성종 |
가톨릭의대 |
교육시간 |
2019-06-20 |
16:20~16:40 |
Surveillance and risk-reducing strategies for breast cancer in women with BRCA mutations |
박형석 |
연세의대 |
교육시간 |
2019-06-20 |
16:40~17:00 |
Precision medicine in gynecologic cancer |
주웅 |
이화의대 |
교육시간 |
2019-06-20 |
15:20~15:45 |
Studies on developing prediction models based on cancer transcroptome and clinical information |
이민호 |
가톨릭대 |
교육시간 |
2019-06-20 |
15:45~16:10 |
Enhancer remodeling and microRNA alterations are associated with acquired resistance to ALK inhibitors |
김미랑 |
한국생명공학연구원 |
교육시간 |
2019-06-20 |
16:10~16:35 |
Genomic research and clinical applications in breast cancer |
한원식 |
서울의대 |
교육시간 |
2019-06-20 |
16:35~17:00 |
Molecular classification reveals new driver transcripts in liver cancer |
우현구 |
아주의대 |
교육시간 |
2019-06-20 |
15:20~15:50 |
The galapagos of the medical research field - An opportunity for the future of medicine in the Korean Peninsula |
김신곤 |
고려의대 |
교육시간 |
2019-06-20 |
15:50~16:20 |
R&D initiatives in DPRK |
신희영 |
서울의대 |
교육시간 |
2019-06-20 |
16:20~16:50 |
Experience of healthcare project between the South & North Korea |
이윤상 |
나눔인터내셔널 |
토론 |
2019-06-20 |
16:50~17:00 |
Q&A Discussion |
|
|
교육시간 |
2019-06-20 |
15:20~17:00 |
Oral Presentations / International Sessions |
|
|
교육시간 |
2019-06-20 |
15:20~15:55 |
How do we go through the HER+ GC? |
김진수 |
서울의대 |
교육시간 |
2019-06-20 |
15:55~16:30 |
From the start to future in antiangiogenic agent in GC |
라선영 |
연세의대 |
교육시간 |
2019-06-20 |
16:30~17:00 |
Real world evidence of ramucirumab in GC |
이근욱 |
서울의대 |
교육시간 |
2019-06-20 |
17:00~18:00 |
Oral Presentations / International Sessions |
|
|
교육시간 |
2019-06-20 |
17:00~18:00 |
Oral Presentations / International Sessions |
|
|
교육시간 |
2019-06-20 |
17:00~18:00 |
Oral Presentations / International Sessions |
|
|
교육시간 |
2019-06-20 |
17:00~18:00 |
Oral Presentations / International Sessions |
|
|
교육시간 |
2019-06-20 |
17:00~18:00 |
Oral Presentations / International Sessions |
|
|
교육시간 |
2019-06-21 |
09:00~10:00 |
Outstanding Abstract Session |
|
|
교육시간 |
2019-06-21 |
09:00~09:20 |
Mechanisms underlying synergy of Topo I and mTOR co-inhibition in MPNSTs |
기동혁 |
Harvard Medical School/Dana-Farber Cancer Institute, USA |
교육시간 |
2019-06-21 |
09:20~09:40 |
Tumor interferon signaling: Implications for cancer immunotherapy |
신다니엘 |
David Geffen School of Medicine at UCLA, USA |
교육시간 |
2019-06-21 |
09:40~10:00 |
Advancing the promise of chemoimmunotherapy in solid tumors |
원영욱 |
University of Arizona College of Medicine, USA |
토론 |
2019-06-21 |
10:00~10:10 |
Q&A Discussion |
|
|
교육시간 |
2019-06-21 |
09:00~10:00 |
Oral Presentations / International Sessions |
|
|
교육시간 |
2019-06-21 |
09:00~10:00 |
Oral Presentations / International Sessions |
|
|
휴식 |
2019-06-21 |
10:00~10:20 |
Coffee Break |
|
|
교육시간 |
2019-06-21 |
10:20~10:50 |
The complex path to cancer precision medicine |
김열홍 |
고려의대 |
교육시간 |
2019-06-21 |
10:50~11:40 |
Tumor and host factors regulating immunotherapy efficacy versus resistance |
Thomas Gajewski |
University of Chicago, USA |
휴식 |
2019-06-21 |
11:40~11:50 |
Break |
|
|
교육시간 |
2019-06-21 |
11:50~12:50 |
The evolution from “Standard-of-Care” to “Standard-of-Survival”: Unfolding the quantum leap in mNSCLC |
TBA |
TBA |
교육시간 |
2019-06-21 |
11:50~12:50 |
The evolving power of immunotherapy: Atezolizumab in advanced lung cancer |
TBA |
TBA |
교육시간 |
2019-06-21 |
11:50~12:50 |
An optimal post-progression treatment option to improve advanced gastric cancer patient outcomes: Clinical experiences with ramucirumab |
이근욱 |
서울의대 |
기타 |
2019-06-21 |
12:50~13:30 |
KCA General Assembly |
|
|
휴식 |
2019-06-21 |
13:30~13:40 |
Break |
|
|
교육시간 |
2019-06-21 |
13:40~14:10 |
Basic immunology primer I |
TBA |
TBA |
교육시간 |
2019-06-21 |
14:10~14:40 |
Basic immunology primer II |
TBA |
TBA |
교육시간 |
2019-06-21 |
14:40~15:10 |
Basic immunology primer III |
TBA |
TBA |
토론 |
2019-06-21 |
15:10~15:20 |
Q&A Discussion |
|
|
교육시간 |
2019-06-21 |
13:40~14:05 |
Comparison of PD-L1 assays in urothelial carcinoma |
이규상 |
서울의대 |
교육시간 |
2019-06-21 |
14:05~14:30 |
Pathologic interpretation of immune biomarkers in gastric cancer |
김현기 |
연세의대 |
교육시간 |
2019-06-21 |
14:30~14:55 |
Molecular basis of immune response heterogeneity in colorectal cancers: potential biomarkers |
김정호 |
서울의대 |
교육시간 |
2019-06-21 |
14:55~15:20 |
Genomic features associated with transcriptome-based cancer immunoprofiling |
김태민 |
가톨릭의대 |
교육시간 |
2019-06-21 |
13:40~14:10 |
Campaign NOV1801; Anti-4-1BB antibody, an immune checkpoint regulator |
이중원 |
유틸렉스 |
교육시간 |
2019-06-21 |
14:10~14:40 |
Fast follower-Best in class strategy, Pan-TRK inhibitor (NOV1601) |
이상윤 |
한독 |
교육시간 |
2019-06-21 |
14:40~15:10 |
Development of NOV140101(IDX-1197); A novel, selective, and highly potent PARP inhibitor |
최성구 |
일동제약 |
토론 |
2019-06-21 |
15:10~15:20 |
Q&A Discussion |
|
|
교육시간 |
2019-06-21 |
13:40~14:05 |
Single cell RNA-seq in tumor microenvironment |
이세민 |
울산과학기술원 |
교육시간 |
2019-06-21 |
14:05~14:30 |
Targeting CAF-TAM interaction to inhibit cancer metastasis |
Darren Reece Williams |
광주과학기술원 |
교육시간 |
2019-06-21 |
14:30~14:55 |
Cancer-restraining cancer-associated fibroblasts and their roles in tumor progression and immunity |
Atsushi Enomoto |
Nagoya University, Japan |
교육시간 |
2019-06-21 |
14:55~15:20 |
Tumor microenvironment remodeling by intratumoral oncolytic virus to enhance immune checkpoint blockade |
김찬 |
차의대 |
교육시간 |
2019-06-21 |
13:40~15:20 |
Oral Presentations / International Sessions |
|
|
교육시간 |
2019-06-21 |
13:40~15:20 |
Oral Presentations / International Sessions |
|
|
교육시간 |
2019-06-21 |
13:40~14:10 |
Lung cancer I |
TBA |
TBA |
교육시간 |
2019-06-21 |
14:10~14:40 |
Lung cancer II |
TBA |
TBA |
교육시간 |
2019-06-21 |
14:40~15:10 |
Lung cancer III |
TBA |
TBA |
토론 |
2019-06-21 |
15:10~15:20 |
Q&A Discussion |
|
|
휴식 |
2019-06-21 |
15:20~15:40 |
Coffee Break |
|
|
교육시간 |
2019-06-21 |
15:40~16:10 |
Clinical/translational I |
TBA |
TBA |
교육시간 |
2019-06-21 |
16:10~16:40 |
Clinical/translational II |
TBA |
TBA |
교육시간 |
2019-06-21 |
16:40~17:10 |
Clinical/translational III |
TBA |
TBA |
토론 |
2019-06-21 |
17:10~17:20 |
Q&A Discussion |
|
|
교육시간 |
2019-06-21 |
15:40~16:10 |
Neutropenic fever in cancer patients |
이동건 |
가톨릭의대 |
교육시간 |
2019-06-21 |
16:10~16:40 |
Metagenomic analysis |
송주선 |
녹십자 지놈 |
교육시간 |
2019-06-21 |
16:40~17:10 |
Metagenomics in immuno-oncology drug era |
박한수 |
광주과학기술원 |
토론 |
2019-06-21 |
17:10~17:20 |
Q&A Discussion |
|
|
교육시간 |
2019-06-21 |
15:40~16:05 |
Pathological and molecular characterization of oligometastatic disease |
신동훈 |
부산의대 |
교육시간 |
2019-06-21 |
16:05~16:30 |
Surgical treatment of oligometastatic disease |
김현구 |
고려의대 |
교육시간 |
2019-06-21 |
16:30~16:55 |
Radiotherapy for oligometastatic disease of lung cancer |
서양권 |
국립암센터 |
교육시간 |
2019-06-21 |
16:55~17:20 |
Systemic therapy update in oligometastatic disease |
홍숙희 |
가톨릭의대 |
교육시간 |
2019-06-21 |
15:40~16:00 |
CAM use in Korean cancer patients |
권정혜 |
한림의대 |
교육시간 |
2019-06-21 |
16:00~16:20 |
Issues in off-label use for rare cancer |
이대호 |
울산의대 |
교육시간 |
2019-06-21 |
16:20~16:40 |
Cancer survivorship |
박지수 |
연세의대 |
토론 |
2019-06-21 |
16:40~17:20 |
Panel Discussion |
조건희 |
동아일보 |
토론 |
2019-06-21 |
16:40~17:20 |
Panel Discussion |
박우윤 |
충북의대 |
토론 |
2019-06-21 |
16:40~17:20 |
Panel Discussion |
TBA |
TBA |
교육시간 |
2019-06-21 |
15:40~17:20 |
Oral Presentations / International Sessions |
|
|
교육시간 |
2019-06-21 |
15:40~17:20 |
Oral Presentations / International Sessions |
|
|